Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
Trends in Cardiovascular Medicine
|
February 22, 2011
Circulating smooth muscle progenitors and atherosclerosis
Mattia Albiero, Lisa Menegazzo, Gian Paolo Fadini
Cardiovascular & Hematological Disorders Drug Targets
|
January 27, 2010
Pharmacologic targeting of endothelial progenitor cells
Mattia Albiero, Lisa Menegazzo, Angelo Avogaro, et al.
Biofactors (Oxford, England)
|
April 11, 2012
Endothelial progenitor cells in diabetes mellitus
Lisa Menegazzo, Mattia Albiero, Angelo Avogaro, et al.
Cardiovascular Diabetology
|
June 3, 2014
The dipeptidyl peptidase-4 inhibitor saxagliptin improves function of circulating pro-angiogenic cells from type 2 diabetic patients
Nicol Poncina, Mattia Albiero, Lisa Menegazzo, et al.
Atherosclerosis
|
June 22, 2015
Diabetes modifies the relationships among carotid plaque calcification, composition and inflammation
Lisa Menegazzo, Nicol Poncina, Mattia Albiero, et al.
Diabetologia
|
April 20, 2020
Diabetes mellitus impairs circulating proangiogenic granulocytes
Roberta Cappellari, Marianna D'Anna, Lisa Menegazzo, et al.
Experimental Diabetes Research
|
April 5, 2012
Procalcific phenotypic drift of circulating progenitor cells in type 2 diabetes with coronary artery disease
Gian Paolo Fadini, Mattia Albiero, Lisa Menegazzo, et al.
Cell Biology International
|
March 18, 2010
Rosuvastatin stimulates clonogenic potential and anti-inflammatory properties of endothelial progenitor cells
Gian Paolo Fadini, Mattia Albiero, Elisa Boscaro, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
August 1, 2013
Circulating myeloid calcifying cells have antiangiogenic activity via thrombospondin-1 overexpression
Lisa Menegazzo, Mattia Albiero, Renato Millioni, et al.
Diabetes Care
|
April 2, 2010
The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha
Gian Paolo Fadini, Elisa Boscaro, Mattia Albiero, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
Trends in Cardiovascular Medicine
|
February 22, 2011
Circulating smooth muscle progenitors and atherosclerosis
Mattia Albiero, Lisa Menegazzo, Gian Paolo Fadini
Cardiovascular & Hematological Disorders Drug Targets
|
January 27, 2010
Pharmacologic targeting of endothelial progenitor cells
Mattia Albiero, Lisa Menegazzo, Angelo Avogaro, et al.
Biofactors (Oxford, England)
|
April 11, 2012
Endothelial progenitor cells in diabetes mellitus
Lisa Menegazzo, Mattia Albiero, Angelo Avogaro, et al.
Cardiovascular Diabetology
|
June 3, 2014
The dipeptidyl peptidase-4 inhibitor saxagliptin improves function of circulating pro-angiogenic cells from type 2 diabetic patients
Nicol Poncina, Mattia Albiero, Lisa Menegazzo, et al.
Atherosclerosis
|
June 22, 2015
Diabetes modifies the relationships among carotid plaque calcification, composition and inflammation
Lisa Menegazzo, Nicol Poncina, Mattia Albiero, et al.
Diabetologia
|
April 20, 2020
Diabetes mellitus impairs circulating proangiogenic granulocytes
Roberta Cappellari, Marianna D'Anna, Lisa Menegazzo, et al.
Experimental Diabetes Research
|
April 5, 2012
Procalcific phenotypic drift of circulating progenitor cells in type 2 diabetes with coronary artery disease
Gian Paolo Fadini, Mattia Albiero, Lisa Menegazzo, et al.
Cell Biology International
|
March 18, 2010
Rosuvastatin stimulates clonogenic potential and anti-inflammatory properties of endothelial progenitor cells
Gian Paolo Fadini, Mattia Albiero, Elisa Boscaro, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
August 1, 2013
Circulating myeloid calcifying cells have antiangiogenic activity via thrombospondin-1 overexpression
Lisa Menegazzo, Mattia Albiero, Renato Millioni, et al.
Diabetes Care
|
April 2, 2010
The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha
Gian Paolo Fadini, Elisa Boscaro, Mattia Albiero, et al.
Page
of 3